CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in Vivo
Open Access
- 1 June 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (6) , 731-738
- https://doi.org/10.1006/mthe.2002.0598
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- High and Sustained Transgene Expression in Vivo from Plasmid Vectors Containing a Hybrid Ubiquitin PromoterMolecular Therapy, 2001
- Contribution of Plasmid DNA to Hepatotoxicity after Systemic Administration of LipoplexesHuman Gene Therapy, 2001
- Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activityGene Therapy, 2001
- Comprehensive Analysis of the Acute Toxicities Induced by Systemic Administration of Cationic Lipid:Plasmid DNA Complexes in MiceHuman Gene Therapy, 2000
- Liposome-mediated, nonviral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammationGene Therapy, 2000
- Direct Immunologic activities of CpG DNA and implications for gene therapyThe Journal of Gene Medicine, 1999
- Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shockEuropean Journal of Immunology, 1997
- Activation of the Complement System by Synthetic DNA Complexes: A Potential Barrier for Intravenous Gene DeliveryHuman Gene Therapy, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- TRANSCRIPTION FACTORS: Structural Families and Principles of DNA RecognitionAnnual Review of Biochemistry, 1992